News for BioLife Solutions, Inc. (BLFS)

On June 16, 2025, Sarah Aebersold, the Chief Human Resources Officer at BioLife Solutions Inc, sold 711 shares of the company. Following this transaction, the i

On June 10, 2025, Casdin Capital, LLC (Trades, Portfolio) executed a notable transaction involving BioLife Solutions Inc. The firm reduced its holdings in the c

Shares of BioLife Solutions Inc (BLFS) surged 7.35% in mid-day trading on Jun 6. The stock reached an intraday high of $23.21, before settling at $23.08, up

Shares of BioLife Solutions Inc (BLFS) fell 4.80% in mid-day trading on Jun 2. The stock reached an intraday low of $20.54, before recovering slightly to $20.

Shares of BioLife Solutions Inc (BLFS) fell 3.86% in mid-day trading on May 19. The stock reached an intraday low of $22.47, before recovering slightly to $22

PR NewswireBOTHELL, Wash., May 14, 2025 BOTHELL, Wash., May 14, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and suppli

BioLife Solutions (BLFS) to attend five investor conferences in May and June 2025. The company is a leading provider of bioproduction products for the c

Release Date: May 08, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLife Solutions

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NBLFS.OQ - Biolife Solutions IncQ1 2025 BioLife Solutions Inc Earnings CallMay 08, 2025 / 08:30

BioLife Solutions (BLFS) Q1 2025 highlights: 30% revenue growth, strong cell processing momentum, & CGT leadership.

PR NewswireBOTHELL, Wash., May 8, 2025 BOTHELL, Wash., May 8, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a l

PR NewswireBOTHELL, Wash., May 8, 2025 Cell Processing revenue of $21.6 million, up 33% over Q1 2024GAAP gross margin of 63% and non-GAAP adjusted gross ma

Revenue: $23.9 million, surpassing the estimated $22.22 million and marking a 30% increase year-over-year.Loss Per Share (EPS): $-0.01, better than the estimat

BioLife Solutions (BLFS) delivered earnings and revenue surprises of 233.33% and 5.28%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

PR NewswireBOTHELL, Wash., April 30, 2025 BOTHELL, Wash., April 30, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and su

BioLife has improved its financials, with a dominant 70% market share in biopreservation media and high gross margins. Read why I'm neutral on BLFS stock.

Shares of BioLife Solutions Inc (BLFS) fell 0.28% in mid-day trading on Mar 22. The stock reached an intraday low of $24.19, before recovering slightly to $24

BioLife Solutions Inc (BLFS), a prominent developer and supplier of bioproduction tools and services for the cell and gene therapy market, announced on March 18

Shares of BioLife Solutions Inc (BLFS) fell 1.65% in mid-day trading on Mar 21. The stock reached an intraday low of $24.42, before recovering slightly to $25